By Sabela Ojea
Shares of DaVita dropped after the company's guidance for the year fell short of Wall Street expectations.
The stock was down 7% to $164.75 in postmarket trading. Through Thursday's close, shares are up 18% year to date, and have surged 48% over the past 12 months.
The medical care services provider on Thursday said it expects adjusted earnings of $10.20 to $11.30 for 2025. Wall Street analysts expect full-year adjusted earnings of $11.38.
The company's outlook followed an increase in profit and revenue for the fourth quarter.
"Despite a year with unique hurdles, we finished strong in 2024," Chief Executive Javier Rodriquez said.
DaVita posted a net profit of $259.3 million, or $3.09 a share, compared with $150.7 million, or $1.62 a share, for the same period a year earlier.
Stripping out one-time items, the company's earnings per share came in at $2.24. Analysts polled by FactSet had forecast adjusted earnings of $2.13.
Quarterly revenue rose to $3.29 billion from $3.15 billion a year earlier, missing the $3.26 billion expected by Wall Street.
Write to Sabela Ojea at sabela.ojea@wsj.com
(END) Dow Jones Newswires
February 13, 2025 18:54 ET (23:54 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。